A self-assembling catalyst helps to construct complex biological scaffolds
Terpenes and their derivatives exert important biological and pharmaceutical functions. Starting out from a few basic building blocks nature elegantly builds up complex structures. Chemically particularly challenging are bridged ring systems such as eucalyptol. Chemists at the Technische Universität München (TUM) have now developed a catalyst that initiates the formation of such compounds. A special feature of the catalyst...
Dr Gerhard Schwehm, Project Manager for the Rosetta Spacecraft Mission announced as keynote speaker at Engineering Show in April.
The 2015 Engineering Simulation Show, being held at the Derby Roundhouse in April has secured Dr Gerhard Schwehm, the project manager of the epic 2014 Rosetta Spacecraft Mission as its keynote speaker. Head of Solar System Science Operations Division, Dr Schwehm was a key member of the team which made history, when on Wednesday 12th November, 2014 The European Space Agency (ESA) successfully landed a spacecraft...
Milestone payment triggered by first patient enrolment in the phase IIb clinical trial for refractory Crohn’s disease
TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA)...
From 15-18 March, the 3rd International One Health Congress (IOHC2015) will be organized in RAI Amsterdam, the Netherlands.
The 3rd International One Health Congress brings science and policy together aiming at the early recognition and control of emerging (infectious) diseases that have a growing impact on humans, animals and their ecosystems. Attendees from over 60 countries will participate in this high level congress. Nobel laureate Peter Doherty will participate in the opening ceremony as a keynote lecturer. Recent outbreaks of zoonotic diseases all over...
Oxford Global’s marketing and sales campaign for The Biotherapeutics Series has brought about a record number of registration enquiries.
Senior level attendees from big pharma, smaller biotech companies and academic research institutions have already reserved their place across the 2 days, to contribute to high level scientific discussion with like minded peers. Taking place on 20-21 April 2015 at The Novotel London West, the Bio-therapeutic Series consists of:
Experts from Northumbria University, Newcastle, are taking part in an international project to build the world?s biggest and most revolutionary solar telescope.
The $344 million (£220m) Daniel K Inouye Solar Telescope, to be known as DKIST, will be situated on Haleakala Mountain in Maui, Hawaii, and aims to unlock the secrets of the Sun. With a four-metre diameter primary mirror, the super-telescope will be able to pick up unprecedented detail on the Sun?s surface ? the equivalent of being able to examine a £1 coin from a distance of 100km. It is hoped that DKIST will address fundamental...
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
The results, published in Lancet Oncology, showed that men with advanced, aggressive prostate cancer lived more than four months longer on average if they received abiraterone before chemotherapy than if they did not. The trial, led in the UK by Professor Johann de Bono of The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, could fill an important gap in previous evidence for abiraterone’s...
We are pleased to announce that AP Technologies (APT) has been appointed UK and Ireland distributor for Vertilon Corporation.
APT will be responsible for Vertilon's full range of PhotoniQ charge integrating multi-channel Data Acquisition Systems (DAQs), multi-channel photon counting systems, Sensor Interface Boards (SIBs) and accessories. Martin Sharratt, Founder and Director of APT, commented: “I am very excited to add Vertilon’s DAQs to the APT product range – they will be of great interest to customers using our line of silicon photomultipliers (SiPMs) from...
A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer.
The genetic variants are specifically linked to the most common form of breast cancer, oestrogen receptor positive, and provide important insights into how the disease develops. Scientists believe screening women for all the genetic variants so far identified could eventually pick out those at highest risk of breast cancer and improve strategies for preventing the disease. The study was led by scientists at The Institute of Cancer Research...
What studies into male birds tell us about reproduction in later life
Studies into male birds that produce offspring well into their old age could deepen concerns over the trend for delaying parenthood until later in life, for both men and women. An international team of scientists, led by Dr Brian Preston from Liverpool John Moores University (LJMU), have studied the large, flamboyant houbara bustard, for insights into how aging has evolved. In their most recent work, published in...
Blacktrace Holdings Limited, a leading group of companies focused on Productizing Science®, is pleased to announce that with effect from 16th January 2015 it has acquired the assets of ChemiSens AB, based in Lund, Sweden.
ChemiSens has a 30-year proven track record in the development, manufacture and supply of the highest performance reaction calorimeters. These sophisticated systems, which will now be supplied and supported via the Syrris brand, perfectly complement the Syrris product range. Reaction calorimeters are used in a wide range of applications, including carbon capture and sequestration, biological performance, and chemical reaction kinetic and scale-up safety studies.
Read MoreSensiQ Technologies and Inventiva Set up a European Center of Excellence in Surface Plasmon Resonance (SPR) TechnologiesFeb 24, 2015
Based in Dijon, France, the Center will boast a unique offering for drug discovery in Europe, combining Inventiva’s screening platforms and libraries with SensiQ’s instrumentation
SensiQ, a leader in surface plasmon resonance (SPR) technologies and Inventiva, a French drug discovery company focused on therapeutic approaches involving transcription factors and epigenetic targets, today announce the launch of a European Center of Excellence in SPR technologies, using SensiQ® Pioneer Fragment Edition (Pioneer FE) instrumentation. The SPR Center of Excellence is based in Dijon, France. Inventiva’s existing...
This all-new platform is designed to offer greater flexibility and increased productivity for cell biology and genomics customers. From microbiology research and cell-based assays to rapid DNA quantification, the Spark 10M delivers a combination of advanced capabilities and exceptional ease-of-use to simplify your daily work.
At the heart of the Spark 10M are Tecan’s unique Fusion Optics which offer users the choice of filter- or monchromator-based measurements – or even a combination of both – at the touch of a button, meaning laboratories no longer have to make a trade-off between flexibility and sensitivity. This cutting-edge system is complemented by patent-pending High Speed Monochromators (HSM) which provide a complete absorbance scan, from 200 to 1,000 nm, in under five seconds....
Read MoreCzech Prime Minister Inaugurates New Planetarium Equipped with ZEISS Technology in Hradec KrFeb 24, 2015
On January 22, 2015 the Prime Minister of the Czech Republic, Bohuslav Sobotka, officially inaugurated a new planetarium equipped with ZEISS technology in the Czech city of Hradec Králové.
The modern planetarium, which features a 12-meter dome and seats 100 people, forms part of the astronomical observatory complex located on the outskirts of the university city in north-east Bohemia. The auditorium is slightly tilted to ensure that all the members of the audience have an unobstructed view of the fulldome shows. Five ZEISS VELVET projectors specially designed for dome theaters create an absolutely black background...
Olympus has announced the release of two new configurations of the FluoView FVMPE-RS multiphoton laser scanning microscope series - a Gantry microscope frame and an inverted microscope frame.
The flagship offering in the range of Olympus biological microscopes, the FluoView FVMPE-RS series is widely used in life science research. Its high-speed scanner allows observation of ultra-rapid biological responses, and the system can obtain vivid images from as deep as 8 mm below the tissue surface....
Read MoreAccessible TIRF solutions for every applicationFeb 23, 2015
Representing the latest in total internal reflection (TIRF) technology, the newly expanded Olympus cellTIRF family offers systems for all needs, including a new cost-effective one-line illuminator with motorised TIRF angle control.
Olympus expands its range of cellTIRF illuminators and accessories with the new economic one-line illuminator (cellTIRF-1L), which complements the high-end, 4- and 2-line (cellTIRF MITICO 4L/2L) illuminators. Ideally suited for use with laser combiners, the cellTIRF-1L with motorised TIRF angle control offers cost-effective flexibility for system builders. The new illuminator can also be used with 3rd party lasers and enables multi-fluorescence samples to be sequentially imaged at the same penetration depth. Control is effortlessly managed by software integration or via the Olympus Real-Time Controller (RTC) for accurate live cell imaging.
Event organiser, Xmark Media, continues to reach wider audiences with second regional event this year, the Photonex Scotland Photonics Technologies Roadshow is on the horizon.
The Photonex Roadshow will once again make a visit to Scotland this year on Wednesday 3rd June and this time the brand new Technology and Innovation Centre at the University of Strathclyde will be the venue. Encompassing photonics, imaging and light technologies, this is a key event in the Scotland International Year of Light (IYOL) diary. The event combines a lively exhibition with a high-level conference and is expected to attract a large number of visitors from across Scotland...
Cutting-edge TESCAN VEGA3 SEM provides in-house quality control testing of Agar calibration standards and microscopy consumables
Agar Scientific, a leading supplier of microscopy equipment and consumables, has installed a brand new scanning electron microscope at its Stansted headquarters. The new SEM will allow Agar to further increase the standard of its quality control procedures, giving customers complete confidence in the products that the company supplies....
Read MoreSheffield NHS Lab Discusses Move to CytoSure ArraysFeb 20, 2015
New case study follows the successful adoption of OGT’s CytoSure™ platform at Sheffield Children's NHS Foundation Trust
Oxford Gene Technology (OGT), The Molecular Genetics Company, explores how Sheffield Children's NHS Foundation Trust has seamlessly transferred to its CytoSure™ ISCA 8x60k platform, in a new case study entitled Evaluating and switching to CytoSure microarrays. As the result of a highly stringent National Health Service (NHS) tender for the supply of oligo-based cytogenetics research arrays, CytoSure was selected based on...
Thermo Scientific MAbPac HIC-20 and MAbPac HIC-Butyl Columns Join Lineup
Laboratories characterizing monoclonal antibodies (mAb) now have additional hydrophobic interaction chromatography (HIC) selectivity options, thanks to the expanded family of Thermo Scientific MAbPac HIC HPLC columns. New Thermo Scientific MAbPac HIC-20 and MAbPac HIC-Butyl columns join the company’s line of columns for monoclonal antibody analysis, a response to customer demand for additional selectivity options for...
Ongoing research aims to develop technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan
Oncologic imaging is shifting to non- or minimally-invasive methods · The current focus is on developing technologies that can diagnose cancer at cellular level, even before the diseases manifests itself through symptoms · Molecular imaging and nanotechnology will see major innovation and developments · Public-private partnerships have enormous potential to increase research investments and maximize technology growth...
Australia’s new nuclear medicine manufacturing facility is taking shape – a project which will enable Australia to help meet world demand for the most common radionuclide used in nuclear medicine, Molybdenum-99.
The next critical steps in the development of Australia’s new nuclear medicine production facility are now complete, with the bulk of the excavation work finalised and more than 1900m3 of concrete poured, and more than 350 tonnes of steel reinforcement in place. The ANSTO Nuclear Medicine (ANM) project, underway at the Australian Nuclear Science and Technology Organisation (ANSTO), represents a $168.8 million...